| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Edoxaban |
| Brand | Lixiana® |
| Indication | For the prevention of stroke/SE in adults with NVAF and for the treatment/secondary prevention of DVT and PE in adults. |
| Assessment Process | |
| Rapid review commissioned | 26/06/2015 |
| Rapid review completed | 10/07/2015 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |